Viyash Scientific Limited has released its audited financial results for the quarter and year ended March 31, 2026. The company reported a significant increase in annual consolidated revenue to ₹34,203.10 million, alongside a consolidated net profit of ₹1,772.80 million for the year. The Board has decided against recommending a dividend for FY 2025-26 to prioritize resource conservation, while also approving a major employee stock option plan to incentivize its workforce.
Annual Financial Performance
For the financial year ended March 31, 2026, Viyash Scientific Limited demonstrated robust growth. The consolidated revenue from operations reached ₹34,203.10 million, marking a substantial increase over the previous year. The consolidated net profit attributable to the company’s owners stood at ₹1,772.80 million. The company has maintained a strong balance sheet with total assets reported at ₹46,283.90 million.
Strategic Developments and Employee Initiatives
The Board of Directors, at its meeting held on May 19, 2026, took several key strategic decisions. Beyond the financial reporting, the company announced the approval of the Viyash Scientific Limited Employee Stock Option Scheme 2026. Under this scheme, the Board has authorized the grant of 1,30,98,000 stock options to eligible employees, with an exercise price of ₹101 per option. This initiative aims to align employee interests with the long-term growth of the company.
Corporate Governance and Resource Allocation
In a move to strengthen corporate governance, the company will adopt a new set of Articles of Association to ensure full compliance with the current legal framework, subject to shareholder approval. Furthermore, to effectively manage and conserve financial resources for future growth and operational requirements, the Board has not recommended any dividend payout for the FY 2025-26.
Source: BSE
